Share on StockTwits
 

Equities researchers at Oppenheimer boosted their target price on shares of Lannett Co. (NYSE:LCI) from $41.00 to $45.00 in a research report issued on Friday, Stock Ratings Network.com reports. The firm currently has an “outperform” rating on the stock. Oppenheimer’s price target indicates a potential upside of 25.14% from the stock’s previous close.

Other equities research analysts have also recently issued reports about the stock. Analysts at Zacks downgraded shares of Lannett Co. from an “outperform” rating to a “neutral” rating in a research note to investors on Monday, January 13th. They now have a $37.80 price target on the stock. Analysts at Roth Capital raised their price target on shares of Lannett Co. to $34.00 in a research note to investors on Friday, November 15th. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $33.70.

Lannett Co. (NYSE:LCI) traded up 12.30% during mid-day trading on Friday, hitting $35.97. The stock had a trading volume of 1,256,838 shares. Lannett Co. has a 52-week low of $6.58 and a 52-week high of $38.16. The stock has a 50-day moving average of $34.35 and a 200-day moving average of $23.96. The company has a market cap of $1.251 billion and a P/E ratio of 209.35.

Lannett Co. (NYSE:LCI) last issued its quarterly earnings data on Thursday, February 6th. The company reported $0.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.07. The company had revenue of $67.30 million for the quarter, compared to the consensus estimate of $62.21 million. The company’s revenue for the quarter was up 84.1% on a year-over-year basis. Analysts expect that Lannett Co. will post $1.50 EPS for the current fiscal year.

Lannett Company, Inc is engaged in developing, manufacturing, marketing and distributing generic versions of branded pharmaceutical products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.